| |
| |
|
| Insider
Information: |
Patel Dinesh V Ph D |
| Relationship: |
President and CEO, Dir... |
| City: |
Milpitas |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
549,590 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16,108,483 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
549,590 |
|
|
| Total
Value |
$16,108,483 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -72.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
President and CEO, Dir... |
2024-04-01 |
549,590 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
219,259 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
82,050 |
345,829 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
28,750 |
386,014 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
451,144 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
508,408 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
615,111 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
84,875 |
619,222 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2017-12-20 |
4 |
AS |
$19.55 |
$34,987 |
D/D |
(1,790) |
190,437 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2017-12-21 |
4 |
AS |
$19.56 |
$160,570 |
D/D |
(8,210) |
190,437 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2021-01-19 |
4 |
AS |
$24.60 |
$611,105 |
D/D |
(24,846) |
426,144 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2023-12-13 |
4 |
AS |
$20.08 |
$1,506,000 |
D/D |
(75,000) |
534,347 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2024-03-01 |
4 |
AS |
$31.62 |
$948,600 |
D/D |
(30,000) |
574,590 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2024-04-01 |
4 |
AS |
$28.31 |
$707,750 |
D/D |
(25,000) |
549,590 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2019-12-03 |
4 |
B |
$5.55 |
$168,500 |
D/D |
30,000 |
409,824 |
2.81 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2022-02-28 |
4 |
D |
$24.28 |
$112,853 |
D/D |
(4,648) |
503,760 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2023-05-31 |
4 |
D |
$26.07 |
$317,142 |
D/D |
(12,165) |
602,946 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2024-02-15 |
4 |
D |
$28.23 |
$104,931 |
D/D |
(3,717) |
615,505 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2024-02-26 |
4 |
D |
$29.53 |
$322,320 |
D/D |
(10,915) |
604,590 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2018-07-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
263,779 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2020-04-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
437,990 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2022-05-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
581,048 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2022-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,116 |
598,096 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2023-02-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
583,448 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEOOfficer |
• • – |
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
131,976 |
|
- |
|
| PTGX |
Protagonist Therapeutics,... |
President and CEO |
• • – |
2016-12-22 |
5 |
OE |
$0.87 |
$2,610 |
D/D |
3,000 |
134,976 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
